Search

Tatiana I Novobrantseva

age ~51

from Wellesley, MA

Also known as:
  • Tatiano Novobrantseva
  • Tatiana A
Phone and address:
15 High Ledge Ave, Wellesley, MA 02482

Tatiana Novobrantseva Phones & Addresses

  • 15 High Ledge Ave, Wellesley, MA 02482
  • 1 Penacook Ln, Natick, MA 01760
  • 175 Harvard St, Brookline, MA 02446
  • Waltham, MA
  • 158 Quincy Shore Dr, Quincy, MA 02171 • 6174721216

Education

  • Degree:
    High school graduate or higher

Us Patents

  • Compositions And Methods For Inhibiting Expression Of Factor Vii Gene

    view source
  • US Patent:
    7871985, Jan 18, 2011
  • Filed:
    Dec 10, 2008
  • Appl. No.:
    12/331708
  • Inventors:
    Antonin de Fougerolles - Cambridge MA, US
    Tatiana Novobrantseva - Cambridge MA, US
    Akin Akinc - Cambridge MA, US
  • Assignee:
    Alnylam Pharmaceuticals, Inc. - Cambridge MA
  • International Classification:
    C07H 21/02
    C07H 21/04
    A61K 31/70
    A01N 43/04
  • US Classification:
    514 44, 536 231, 536 243, 536 2433, 536 245
  • Abstract:
    The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of the Factor VII gene.
  • Compositions And Methods For Inhibiting Expression Of A Gene From The Ebola Virus

    view source
  • US Patent:
    7973020, Jul 5, 2011
  • Filed:
    May 27, 2010
  • Appl. No.:
    12/789414
  • Inventors:
    Sina Bavari - Frederick MD, US
    Kelly Lyn Warfield - Adamstown MD, US
    Pamela Tan - Kulmbach, DE
    Anna Borodovsky - Cambridge MA, US
    Tatiana Novobrantseva - Wellesley MA, US
    Antonin de Fougerolles - Brookline MA, US
  • Assignee:
    Alnylam Pharmaceuticals, Inc. - Cambridge MA
    The United States of America as represented by the Secretary of the Army - Washington DC
  • International Classification:
    C07H 21/02
    C07H 21/04
    A61K 31/70
  • US Classification:
    514 44, 536 231, 536 243, 536 2433, 536 245
  • Abstract:
    The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a gene from the Ebola virus.
  • Enhancement Of Influenza Gene Expression

    view source
  • US Patent:
    8227188, Jul 24, 2012
  • Filed:
    Sep 3, 2010
  • Appl. No.:
    12/875695
  • Inventors:
    Antonin de Fougerolles - Brookline MA, US
    Tatiana Novobrantseva - Quincy MA, US
    Pamela Tan - Kulmbach, DE
    Anke Geicke - Bayreuth, DE
    Rachel Meyers - Newton MA, US
  • Assignee:
    Alnylam Pharmaceuticals, Inc. - Cambridge MA
  • International Classification:
    C12Q 1/68
  • US Classification:
    435 6, 435325, 435375, 536 245, 536 2431
  • Abstract:
    The invention relates to compositions and methods for modulating the expression of influenza viral genes, and more particularly to the downregulation of influenza viral genes by chemically modified oligonucleotides.
  • Compositions And Methods For Inhibiting Expression Of Cd45 Gene

    view source
  • US Patent:
    8288525, Oct 16, 2012
  • Filed:
    Feb 12, 2009
  • Appl. No.:
    12/867230
  • Inventors:
    Antonin de Fougerolles - Brookline MA, US
    Pamela Tan - Kulmbach, DE
    Anna Borodovsky - Cambridge MA, US
    Tatiana Novobrantseva - Wellesley MA, US
    Sina Bavari - Frederick MD, US
    Kelly Lyn Warfield - Adamstown MD, US
  • Assignee:
    Alnylam Pharmaceuticals, Inc. - Cambridge MA
  • International Classification:
    C12Q 1/68
  • US Classification:
    536 245, 536 241, 536 2431, 514 44, 435 6, 435325, 435375
  • Abstract:
    The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of the CD45 gene.
  • Compositions And Methods For Inhibiting Expression Of Factor Vii Gene

    view source
  • US Patent:
    8334273, Dec 18, 2012
  • Filed:
    Dec 16, 2010
  • Appl. No.:
    12/970673
  • Inventors:
    Antonin de Fougerolles - Cambridge MA, US
    Tatiana Novobrantseva - Wellesley MA, US
    Akin Akinc - Needham MA, US
  • Assignee:
    Alnylam Pharmaceuticals, Inc. - Cambridge MA
  • International Classification:
    A61K 31/70
    C07H 21/02
    C07H 21/04
    C12Q 1/68
    C12P 19/34
  • US Classification:
    514 44A, 536 245, 435 61, 435 911, 435325, 435375
  • Abstract:
    The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of the Factor VII gene.
  • Compositions And Methods For Inhibiting Expression Of A Gene From The Ebola Virus

    view source
  • US Patent:
    8354390, Jan 15, 2013
  • Filed:
    Apr 25, 2011
  • Appl. No.:
    13/093681
  • Inventors:
    Sina Bavari - Frederick MD, US
    Kelly Lyn Warfield - Adamstown MD, US
    Pamela Tan - Kulmbach, DE
    Anna Borodovsky - Cambridge MA, US
    Tatiana Novobrantseva - Wellesley MA, US
    Antonin de Fougerolles - Brookline MA, US
  • Assignee:
    Alnylam Pharmaceuticals, Inc. - Cambridge MA
    The United States of America, as represented by the Secretary of the Army - Washington DC
  • International Classification:
    A61K 31/70
    C07H 21/02
    C07H 21/04
  • US Classification:
    514 44A, 536 241, 536 245
  • Abstract:
    The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a gene from the Ebola virus.
  • Compositions And Methods For Inhibiting Expression Of Cd274/Pd-L1 Gene

    view source
  • US Patent:
    8507663, Aug 13, 2013
  • Filed:
    Apr 6, 2011
  • Appl. No.:
    13/081270
  • Inventors:
    Antonin Defougerolles - Cambridge MA, US
    Tatiana Novobrantseva - Cambridge MA, US
    Brian Bettencourt - Cambridge MA, US
  • Assignee:
    Alnylam Pharmaceuticals, Inc. - Cambridge MA
  • International Classification:
    C07H 21/04
    C07H 21/02
    A61K 48/00
    C12N 15/63
  • US Classification:
    536 245, 536 231, 514 44, 4353201
  • Abstract:
    The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the CD274/PD-L1 gene, and methods of using such dsRNA compositions to inhibit expression of CD274/PD-L1.
  • Lipid Formulated Compositions And Methods For Inhibiting Expression Of Serum Amyloid A Gene

    view source
  • US Patent:
    8546554, Oct 1, 2013
  • Filed:
    Sep 25, 2009
  • Appl. No.:
    13/120601
  • Inventors:
    Antonin de Fougerolles - Brookline MA, US
    Tatiana Novobrantseva - Wellesley MA, US
    Gregory Hinkle - Plymouth MA, US
  • Assignee:
    Alnylam Pharmaceuticals, Inc. - Cambridge MA
  • International Classification:
    C07H 21/04
    C07H 21/02
    C12N 15/85
    A61K 48/00
  • US Classification:
    536 245, 536 231, 435325, 514 44
  • Abstract:
    The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting a Serum Amyloid A (SAA) gene, and methods of using the dsRNA to inhibit expression of SAA.

Mylife

Tatiana Novobrantseva Photo 1

Tatiana Novobrantseva We...

view source
It's time to get back in touch with a lost friend like Tatiana Novobrantseva of Wellesley. Rekindle old friendships at MyLife.

Get Report for Tatiana I Novobrantseva from Wellesley, MA, age ~51
Control profile